S C Wilkie
Overview
Explore the profile of S C Wilkie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilkie S, Hislop L, Miller S
Emerg Med J
. 2001 Apr;
18(2):145.
PMID: 11300196
No abstract available.
2.
McGuffie A, Wilkie S, Kerr G
Scott Med J
. 2000 Sep;
45(3):75-6.
PMID: 10986740
To determine emergency management of overdose relating to gastrointestinal decontamination procedures in Scottish Accident & Emergency (A & E) Departments. A postal questionnaire was sent to the 28 main A...
3.
Kerr G, Wilkie S, McGuffie C
Br J Sports Med
. 1999 Aug;
33(4):274-5.
PMID: 10450484
Objectives: To determine if doctors providing medical care at Scottish football stadiums meet the standards recommended by the Gibson Report. Methods: A postal questionnaire and telephone follow up of doctors...
4.
Rodriguez M, SNYDER N, Zweifel M, Wilkie S, Stack D, Cooper R, et al.
J Antibiot (Tokyo)
. 1998 Aug;
51(6):560-9.
PMID: 9711219
LY264826 (A82846B) is a naturally-occurring glycopeptide antibiotic, differing from vancomycin in the stereochemistry of the amino-sugar of the disaccharide function, and the presence of a third sugar attached at the...
5.
Solenberg P, Matsushima P, Stack D, Wilkie S, Thompson R, Baltz R
Chem Biol
. 1997 Mar;
4(3):195-202.
PMID: 9115410
Background: The glycopeptide antibiotics vancomycin and teicoplanin are currently the last line of defence against some microorganisms that are resistant to many drugs. The emergence of vancomycin-resistant and teicoplanin-resistant enterococci...
6.
Nicas T, Mullen D, Flokowitsch J, Preston D, SNYDER N, Zweifel M, et al.
Antimicrob Agents Chemother
. 1996 Sep;
40(9):2194-9.
PMID: 8878606
Certain derivatives of the glycopeptide antibiotic LY264826 with N-alkyl-linked substitutions on the epivancosamine sugar are active against glycopeptide-resistant enterococci. Six compounds representing our most active series were evaluated for activity...
7.
Cooper R, SNYDER N, Zweifel M, Staszak M, Wilkie S, Nicas T, et al.
J Antibiot (Tokyo)
. 1996 Jun;
49(6):575-81.
PMID: 8698642
Reductive alkylation of the A82846 family of glycopeptide antibiotics has the potential of producing seven products. N-Alkylation of the disaccharide amino function can be accomplished selectively, and offers the greatest...